The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy

AIM: To explore the role of Rac1 on sorafenib resistance in hepatocellular carcinoma. METHODS: CCK-8, wound healing assay, Transwell, and cell cycle assay were used to detect the tumor cells development. Cell viability was assessed by MTT. The glycolytic pathway was revealed by cellular metabolism a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yin-Xiang, Li, Xiao-Bin, Liu, Wei, Yang, Xu-Guang, Liu, Xin, Luo, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279021/
https://www.ncbi.nlm.nih.gov/pubmed/35847360
http://dx.doi.org/10.1155/2022/7319641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279021/
https://www.ncbi.nlm.nih.gov/pubmed/35847360
http://dx.doi.org/10.1155/2022/7319641

Ejemplares similares